Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Clarapath logo — Pioneering a future of precision in pathology with automated...

Clarapath

Pioneering a future of precision in pathology with automated solutions that promise superior quality, enhanced safety, and efficiency in lab operations.

Founded 2014 United States Hawthorne, United States 63 employees Series B Total: $75.16M Biotechnology, Health Care

General Information

Company Name Clarapath
Founded Year 2014
Location United States Hawthorne, United States
Employees 63
Industries Biotechnology, Health Care
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Clarapath. To contact Clarapath, visit clarapath.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Clarapath compare?

A PDF of Clarapath and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Clarapath soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Clarapath

Clarapath is a pioneering medical robotics company founded in 2014, with a vision to automate laboratory processes in pathology. The company's flagship product focuses on fully automating the microtomy station, aiming to enhance, standardize, and digitalize anatomic pathology. Located at the NY Genome Center, Clarapath's next-generation laboratory, extensive image repository, and analysis platform are equipped to manage the entire "tissue to bits" pipeline for specialized research projects and larger clinical needs. With a recent $16.00M Series B investment received on 17 November 2021 from Northwell Health, P5 Health Ventures, Epiphron Capital, The 4100 Group, and East Post Road Ventures, Clarapath is well-positioned to advance its mission of delivering superior quality, enhanced safety, and efficiency in lab operations. Through partnerships with both research and clinical clients, the company aims to offer higher-quality lab medicine, improved safety standards, and increased lab throughput while reducing laboratory costs and labor delays. As a biotechnology and healthcare industry player, Clarapath stands at the forefront of pioneering a future of precision in pathology with its automated solutions.

Business keywords: medical robotics, pathology automation, laboratory operations, anatomic pathology, precision medicine, digital pathology, clinical research, laboratory automation, NY Genome Center, tissue analysis, lab safety, efficiency in lab operations, image repository

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $36.00M 4
Mayo Clinic Northwell Health
Mayo Clinic, Northwell Health +2
24 Jul 2024
Series B $16.00M 5
Northwell Health P5 Health Ventures Epiphron Capital
Northwell Health, P5 Health Ventures +3
17 Nov 2021
Series B $16.00M -
01 Apr 2021
Venture Round $4.16M -
27 Nov 2019
Venture Round $3.00M 1
Northwell Health
Northwell Health
01 Feb 2017

Clarapath Alternatives & Competitors

View All Alternatives
Clarapath vs
Aperio
Aperio United States

For over a decade, Aperio has advanced the technology that enables glass slides to be digitized and...

Debt Financing
86 employees
Biotechnology, Health Care
Compare Clarapath vs Aperio
Clarapath vs
BioImagene
BioImagene United States

Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissu...

Series D
37 employees
Biotechnology, Health Care
Compare Clarapath vs BioImagene
Clarapath vs
Virasoft Corporation
Virasoft Corporation United States

Connecting People. Elevating Patient Care. Complete Pathology Workflows with Integrated Digital Path...

43 employees
AI, Biotechnology
View all alternatives

FAQ About Clarapath

Pioneering a future of precision in pathology with automated solutions that promise superior quality, enhanced safety, and efficiency in lab operations.
Clarapath was founded in 2014.
Clarapath is headquartered in Hawthorne, United States.
Clarapath operates in Biotechnology and Health Care. Its work centres on medical robotics, pathology automation, laboratory operations and anatomic pathology.
Clarapath has approximately 63 employees.
Clarapath has completed 5 funding rounds, raising a total of $75.16M. The latest funding stage is Series B.
Top alternatives and competitors to Clarapath include Aperio, BioImagene, Virasoft Corporation, Precision For Medicine, xMD Diagnostics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Clarapath and Aperio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Clarapath, https://www.bouncewatch.com/company/clarapath, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout